NTHI — NEONC TECHNOLOGIES HOLDINGS, INC. catalysts

Name: Bio Catalyst Calendar — source-anchored biotech/pharma catalyst dates
Creator: Bio Catalyst Calendar
License: https://www.usa.gov/government-works

3 verified catalyst event(s) for NEONC TECHNOLOGIES HOLDINGS, INC. (ticker NTHI). Each is linked to its official source. Verified as of 2026-11-04.

Next verified catalyst

2026-11-30 — Safety and Efficacy Study in Recurrent or Progressive Grade III or IV IDH1 Mutated Glioma · official source ↗

Upcoming

Date	Event	Company	Drug	Official source & verification
2026-11-30 in 26d ESTIMATED	READOUT Safety and Efficacy Study in Recurrent or Progressive Grade III or IV IDH1 Mutat Phase 1/2 · Glioblastoma Multiforme	NTHI NEONC TECHNOLOGIES HOLDINGS,	Perillyl alcohol	ClinicalTrials.gov ↗ ✓ Source-checked 2026-11-04 Sponsor-projected date — can change
2026-12-30 in 2mo ESTIMATED	READOUT NEO100 and High-Grade Meningioma Phase 2 · Residual, Progressive or Recurrent Grade II or III Meningioma	NTHI NEONC TECHNOLOGIES HOLDINGS,	NEO100	ClinicalTrials.gov ↗ ✓ Source-checked 2026-11-04 Sponsor-projected date — can change
2027-02-28 in 4mo ESTIMATED	READOUT Safety and Efficacy of NEO212 in Patients With Astrocytoma IDH-mutant, Glioblast Phase 1/2 · Diffuse Astrocytoma, IDH-Mutant, Glioblastoma, IDH-wildtype	NTHI NEONC TECHNOLOGIES HOLDINGS,	NEO212 Oral Capsule, Ipilimumab, Pembrol	ClinicalTrials.gov ↗ ✓ Source-checked 2026-11-04 Sponsor-projected date — can change